38
別紙４
研究成果の刊行に関する一覧表
雑誌
発表者氏名 論文タイトル名 発表誌名 巻号 ページ 出版年 Yamamoto Y,
Goto N, Miura K, Narumi K, Ohnami S, Uchida H, Miura Y, Yamamoto M, Aoki K.
Development of a novel efficient method to construct an adenovirus library displaying random peptides on the fiber knob.
Mol. Pharm. 11 1069-1074 2014
Aida K, Miyakawa R, Suzuki K, Narumi K, Udagawa T, Yamamoto Y, Chikaraishi T, Yoshida T, Aoki K.
Suppression of Tregs by anti-GITR antibody enhances the antitumor immunity of IFN-α gene therapy for pancreatic cancer.
Cancer Sci. 105 159-167 2014
Suzuki K, Aida K, Miyakawa R, Narumi K, Udagawa T, Goto N, Yoshida T, Ohshima Y, Aoki K.
Pre-immunization of donor lymphocytes enhances antitumor immunity of autologous hematopoietic stem cell transplantation.
Cancer Med. 2 636-645 2013
Udagawa T, Narumi K, Suzuki K, Aida K, Miyakawa R, Ikarashi Y, Makimoto A, Chikaraishi T, Yoshida T, Aoki K.
VEGF-D-mediated blockade of regulatory T cells within tumors is induced by hematopoietic stem cell transplantation.
J. Immunol. 191 3440-3452 2013
Kimura J, Ono H, Kosaka T, Makino H, Akiyama H, Ichikawa Y, Nagashima Y, Hirai S, Ohno S, Aoki K, Davydova J, Yamamoto M, Kunisaki C, Endo I.
Conditionally replicative adenoviral vectors for imaging the effect of chemotherapy on pancreatic cancer cells.
Cancer Sci. 104 1083-1090 2013
Miura Y, Yamasaki S, Davydova J, Brown E, Aoki K, Vickers S, Yamamoto M.
Infectivity-selective oncolytic adenovirus developed by
high-throughput screening of
adenovirus-formatted library.
Mol. Ther. 21 139-148 2013
39 Wu D, Hiroshima
K, Matsumoto S, Nabeshima K, Yusa, T, Ozaki D, Fujino M,
Yamakawa H, Nakatani Y, Tada Y, Shimada H, Tagawa M.
Diagnostic usefulness of p16/CDKN2A FISH in distinguishing between sarcomatoid
mesothelioma and fibrous pleuritis.
Am. J. Clin.
Pathol.
139 39-46 2013
Tada Y, Shimada H, Hiroshima K, Tagawa M.
A potential therapeutic strategy for malignant mesothelioma with gene medicine.
BioMed. Res.
Int.
572609 2013
Gotoh A, Nagaya H, Kanno T, Tagawa M, Nishizaki T.
Fiber-substituted conditionally replicating adenovirus Ad5F35 induces oncolysis of human bladder cancer cells in in vitro analysis.
Urology 81:920 e7-920.e11 2013
Tagawa M, Tada Y, Shimada H, Hiroshima K.
Gene therapy for
malignant mesothelioma:
Current prospects and challenges.
Cancer Gene Ther.
20 150-156 2013
Fukamachi T, Ikeda S, Wang X, Saito H, Tagawa M, Kobayashi H.
Gene expressions for signal transduction under acidic conditions.
Genes 4 65-85 2013
Okamoto S, Jiang Y, Kawamura K, Shingyoji M, Fukamachi T, Tada Y, Takiguchi Y, Tatsumi K, Shimada H, Hiroshima K, Kobayashi H, Tagawa M.
Zoledronic acid produces combinatory anti-tumor effects with cisplatin on mesothelioma by
increasing p53 expression levels.
PLoS ONE 8 e60297 2013
Li Q, Kawamura K, Tada Y, Shimada H, Hiroshima K, Tagawa M.
Novel type III interferons produce anti-tumor effects through multiple functions.
Front. Biosci. 18 909-918 2013
40 Li Q, Kawamura
K, Yang S, Okamoto S, Kobayash H, Tada Y, Sekin I, Takiguchi Y, Shingyouji M, Tatsumi K, Shimada H, Hiroshima K, Tagawa M.
Interferon- produces synergistic combinatory anti-tumor effects with cisplatin or pemetrexed on mesothelioma cells.
PLoS ONE 8 e72709 2013
Kawamura K, Hiroshima K, Suzuki T, Chai K, Yamaguchi N, Shingyoji M, Yusa T, Tada Y,
Takiguchi Y, Tatsumi K, Shimada H, Tagawa M.
CD90 is a diagnostic marker to differentiate between malignant pleural mesothelioma and lung carcinoma with immunohistochemistry.
Am. J. Clin.
Pathol.
140 544-549 2013
Takagi-Kimura M, Yamano T, Tamamoto A, Okamura N, Okamura H, Hashimoto-Tamao ki T, Tagawa M, Kasahara N, Kubo S.
Enhanced antitumor efficacy of
fiber-modified, midkine promoter-regulated oncolytic adenovirus in human malignant mesothelioma.
Cancer Sci. 104 1433-1439 2013
Zhang M, Kawamura K, Jiang Y, Shingyoji M, Ma G, Li Q, Hu J, Qi Y, Liu H, Zhang F, Kang S, Shan B, Wang S, Chada S, Tagawa M.
Heat-shock protein 90 inhibitors synergistically enhance melanoma differentiation-associated gene-7-mediated cell killing of human pancreatic carcinoma.
Cancer Gene Ther.
20 663-670 2013
Ma G, Kawamura K, Yang S, Okamoto S, Li Q, Namba M, Shingyoji M, Tada Y, Tatsumi K, Hiroshima K, Shimada H, Tagawa M.
Combination of
adenoviruses expressing melanoma
differentiation-associated gene-7 and
chemotherapeutic agents produces enhanced cytotoxicity on esophageal carcinoma.
Cancer Gene Ther.
21 31-37 2014
Tagawa M. Gene therapy in malignant pleural mesothelioma.
Lung Cancer Manage.
3 29-33 2013
41 Takagi-Kimura M,
Yamano T, Tagawa M, Kubo S.
Oncolytic virotherapy for osteosarcoma using midkine
promoter-regulated adenoviruses.
Cancer Gene Ther.
In press
Fukamachi T, Ikeda S, Saito H, Tagawa M, Kobayashi H.
Expression of
acidosis-dependent genes in human cancer nests.
Mol. Clin.
Oncol.
In press
Tagawa M, Shirane K, Yu L, Sato T, Furukawa S, Mizuguchi H, Kuji R, Kawamura K, Takahashi N, Kato K, Hayakawa S, Sawada S, Furukawa K.
Enhanced expression of the 4-galactosyltransferase 2 gene impairs the mammalian tumor growth.
Cancer Gene Ther.
In press
Wang PY, Currier MA, Hansford L, Kaplan D, Chiocca EA, Uchida H, Goins WF, Cohen JB, Glorioso JC, Kuppevelt TH, Mo X, Cripe TP.
Expression of HSV-1 receptors in
EBV-associated lymphoproliferative disease determines susceptibility to oncolytic HSV.
Gene Ther. 20 761-769 2013
Uchida H, Marzulli M, Nakano K, Goins WF, Chan J, Hong CS,
Mazzacurati L, Yoo JY, Haseley A, Nakashima H, Baek H, Kwon H, Kumagai I, Kuroki M, Kaur B, Chiocca EA, Grandi P, Cohen JB, Glorioso JC.
Effective treatment of an orthotopic xenograft model of human glioblastoma using an EGFR-retargeted oncolytic herpes simplex virus.
Mol. Ther. 21 561-569 2013
Uchida H, Chan J, Shrivastava I, Reinhart B, Grandi P, Glorioso JC, Cohen JB.
Novel mutations in gB and gH circumvent the requirement for known gD receptors in HSV-1 entry and cell-to-cell spread.
J. Virol. 87 1430-1442 2013
Matsui H, Sakurai F, Katayama K, Abe Y, Machitani M, Kurachi S, Tachibana M, Mizuguchi H.
A targeted adenovirus vector displaying a human fibronectin type III domain-based monobody in a fiber protein.
Biomaterials 34 4191-4201 2013
42 Machitani M,
Sakurai F, Katayama K, Tachibana M, Suzuki T, Matsui H, Yamaguchi T, Mizuguchi H.
Improving adenovirus vector-mediated RNAi efficiency by lacking the expression of
virus-associated RNAs.
Virus Res. 178 357-363 2013
Yukawa H, Tsukamoto R, Kano A, Okamoto Y, Tokeshi M, Ishikawa T, Mizuno M, Baba Y.
Quantum Dots Conjugated with Transferrin for Brain Tumor Cell Imaging,
J. Cell. Sci.
Ther.
4 150- doi:10.
4172/2157-7 013.1000150
2013
Utsumi F, Kajiyama H, Nakamura K, Tanaka H, Mizuno M, Ishikawa K, Kondo H, Kano H, Hori M, Kikkawa F.
Effect of indirect nonequilibrium atmospheric pressure plasma on
anti-proliferative activity against chronic chemo-resistant ovarian cancer cells in vitro and in vivo.
PLos One 8 e81576 2013
